PDL BIOPHARMA INC's ticker is and the CUSIP is 69329YAF1.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2017 | $21,000 | 0.0% | 21,000 | 0.0% | 0.00% | – |
| Q3 2017 | $21,000 | 0.0% | 21,000 | 0.0% | 0.00% | – |
| Q2 2017 | $21,000 | -54.3% | 21,000 | -54.3% | 0.00% | – |
| Q1 2017 | $46,000 | +48.4% | 46,000 | +48.4% | 0.00% | – |
| Q4 2016 | $31,000 | -51.6% | 31,000 | -53.0% | 0.00% | – |
| Q3 2016 | $64,000 | +137.0% | 66,000 | +127.6% | 0.00% | – |
| Q2 2016 | $27,000 | +50.0% | 29,000 | +45.0% | 0.00% | – |
| Q1 2016 | $18,000 | -21.7% | 20,000 | -33.3% | 0.00% | – |
| Q4 2015 | $23,000 | -91.6% | 30,000 | -90.3% | 0.00% | – |
| Q3 2015 | $273,000 | +396.4% | 308,000 | +431.0% | 0.00% | – |
| Q2 2015 | $55,000 | +111.5% | 58,000 | +114.8% | 0.00% | – |
| Q1 2015 | $26,000 | +36.8% | 27,000 | +35.0% | 0.00% | – |
| Q4 2014 | $19,000 | -51.3% | 20,000 | -50.0% | 0.00% | – |
| Q3 2014 | $39,000 | +69.6% | 40,000 | +100.0% | 0.00% | – |
| Q2 2014 | $23,000 | -34.3% | 20,000 | -39.4% | 0.00% | – |
| Q1 2014 | $35,000 | – | 33,000 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Radcliffe Capital Management, L.P. | 19,703,000 | $19,738,000 | 2.83% |
| ASCEND CAPITAL, LLC | 43,840,000 | $43,727,000 | 1.65% |
| ZAZOVE ASSOCIATES LLC | 2,080,000 | $2,085,000 | 0.11% |
| Verition Fund Management LLC | 1,000,000 | $1,004,000 | 0.08% |
| OAKTREE CAPITAL MANAGEMENT LP | 4,940,000 | $4,940,000 | 0.07% |
| COMMONWEALTH OF PENNSYLVANIA PUBLIC SCHOOL EMPLS RETRMT SYS | 3,420,000 | $3,424,000 | 0.05% |
| UBS ASSET MANAGEMENT AMERICAS LLC | 37,800,000 | $37,702,476,000 | 0.03% |
| Sterneck Capital Management, LLC | 18,000 | $18,000 | 0.01% |
| ADVENT CAPITAL MANAGEMENT /DE/ | 235,000 | $212,000 | 0.00% |
| INVESTMENT CENTERS OF AMERICA INC | 50,000 | $50,000 | 0.00% |